2013 was a stellar year for stocks. And few sectors performed as well as biotechnology. The Dow Jones industrial average may have turned in a fantastic 28% increase for 2013, and the Nasdaq Composite 41%, but the Nasdaq Biotechnology Index soared 68%. Along with an increased interest in investing in this sector, there has been a surge of biotech IPOs -- in numbers not seen for many years.
↧